Althea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance

MT Newswires Live

05/07

Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.

Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.

Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2533462266"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533462266\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533462266?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-07 11:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533462266","market":"hk","top_or_hot":-1,"title":"Althea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance","media":"MT Newswires Live","content":"<html><body><p> Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.</p><p>Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.</p><p>Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Althea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlthea Group Holdings Sells Pharmaceutical Segment, Withdraws Fiscal Year 2025 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-07 11:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.</p><p>Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.</p><p>Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7096","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2533462266","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533462266","pubTimestamp":1746589005,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Althea Group Holdings  has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7096":"制药","AGH.AU":"ALTHEA GROUP HOLDINGS LTD","BK7502":"大麻概念"},"translate_title":"Althea Group Holdings出售制药部门，撤回2025财年指引","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AGH.AU":0.9},"content_text":"Althea Group Holdings (ASX:AGH) has signed a binding term sheet to sell its pharmaceutical assets to Tasmanian Botanics for AU$1 million, plus a revenue-sharing arrangement on residual inventory sales, according to a Wednesday Australian bourse filing.Under the deal, the company will be owed 50% of net revenue from any residual inventory sales.Consequently, the company has withdrawn its revenue and earnings before interest, tax, depreciation, and amortization guidance for the fiscal year ending June 30.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}